The board of directors of Abbott (NYSE:ABT) approved a quarterly dividend of USD0.45 per share of the company's common stock, it declared on Friday.
This cash dividend is due on 16 August 2021 to shareholders of record at the close of business as of 15 July 2021.
In addition, the payment marks the company's 390th consecutive quarterly dividend since 1924. It has increased its dividend payout for 49 consecutive years and is a member of the S&P 500 Dividend Aristocrats Index.
According to the healthcare company, it provides a portfolio of life-changing healthcare technologies products, diagnostics, medical devices and nutritionals, as well as branded generic medicines.
Bruker Corporation to acquire ELITechGroup for EUR870m, strengthening MDx portfolio
Perrigo announces quarterly dividend increase
Bruker expands Preclinical Imaging Portfolio with acquisition of Spectral Instruments Imaging
Fusion Antibodies announces receipt of follow-on project and provides R&D update
Alvotech reports positive results for AVT03, potential biosimilar to Prolia and Xgeva
Biosenic finalises agreement with Phebra for oral arsenic troxide development